DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
Explore the future of healthcare with carefully selected information.
Login
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open
innovation from Tokyo, where you can experience the intersection of cool and passionate design and
technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
AGC Biologics-Manufactured Gene Therapy Drug Waskyra™ for Rare Immune Disorders Receives Marketing Authorization in US and Europe
AGC Biologics, a biopharmaceutical CDMO subsidiary of AGC, has received marketing authorization from the U.S. FDA and European Commission for Waskyra™, an ex vivo gene therapy drug for Wiskott-Aldrich Syndrome, which it manufactured under contract. This innovative therapy modifies the patient's own cells, avoiding donor dependence and rejection risks, thus offering a new treatment option for patients with rare immune disorders. The AGC Group continues to contribute to realizing the value of Well-being through its life science business.
Planetary Eyes India as Global Mycoprotein Hub With Sub-$1/kg Production Goal
Swiss fermentation company Planetary SA is in talks with India's Dhampur Bio Organics Ltd. (DBO) to establish India as a global mycoprotein production hub, targeting a cost below $1 per kilogram. The collaboration would integrate Planetary's BioBlocks™ fermentation technology with DBO's existing sugar production infrastructure. This initiative aims to make highly nutritious and sustainable mycoprotein accessible worldwide, tapping into the $1.3 trillion meat market and helping retailers reduce Scope 3 emissions. The project aligns with India's bioeconomy framework, with DBO planning to export raw mycoprotein and develop local market applications like myco-tikka masala, positioning India as a low-cost manufacturing base.
【PRESS RELEASE】CellFiber Unveils New GMP-Compliant Cell Fiber Fabrication System”CellFiber Extruder” for Regenerative Medicine ～Enabling Efficient and Stable Manufacturing of Cell Therapy Products～
CellFiber Inc. has unveiled its production-scaled, GMP-compliant “CellFiber Extruder,” a cell fiber fabrication system designed to enable efficient and stable large-scale manufacturing of cell therapy products for regenerative medicine. This innovative encapsulation technology, CellFiber®, protects cells in a biomimetic alginate structure, improving functional maintenance and viability. The Extruder system automates production, offers flexibility for various cell cultures, operates as a closed system to minimize contamination, and provides traceability for regulatory compliance, addressing critical bottlenecks in cost-efficient, industrial-scale cell manufacturing globally.
Patent Acquired for Umbilical Cord-Derived Mesenchymal Stromal Cells for Sarcopenia Treatment
Human Life CORD Inc. has acquired a Japanese patent for the use of umbilical cord-derived mesenchymal stromal cells (UC-MSCs) in sarcopenia treatment, based on collaborative research with Nagoya University. This technology demonstrated that UC-MSCs suppress muscle mass reduction in accelerated aging animal models, expanding their application in regenerative medicine for age-related diseases. Leveraging this patent, the company will accelerate R&D for regenerative medicine products targeting sarcopenia and other aging-related conditions, including international patent applications in the US and Europe, clinical research in the Americas, and establishing a manufacturing system through a Japan-US partnership with New York Blood Center Enterprises.
First demonstration of the inhibitory effect of myristic acid on postprandial blood glucose levels in humans
A research team led by Professor Ikuo Sakane of the Graduate School of Science, Chiba University, in collaboration with J-Oil Mills Co., Ltd., Raffine International Co., Ltd., and Shimane University, conducted a clinical trial to analyze the effects of myristic acid (Note 1) (a type of saturated fatty acid (Note 2)) on human postprandial blood glucose levels. The results revealed that myristic acid has a significant inhibitory effect on the rise in human postprandial blood glucose levels.
While saturated fatty acids have traditionally been considered harmful and their excessive intake avoided, this study demonstrates that myristic acid, a type of saturated fatty acid, has a beneficial effect in lowering human postprandial blood glucose levels when consumed in small amounts. Appropriate intake of myristic acid is expected to contribute to health maintenance.
These research findings were published online ahead of print in the academic journal Clinical Nutrition ESPEN on November 26, 2025.
New Technology Development for Gas Carbon Neutralization: e-methane Production Technology Utilizing Bioethanol Developed
Daigas Group has developed a new e-methane production technology, "Ethanol Methanation," which utilizes bioethanol as a raw material. This technology has successfully produced a mixed gas primarily composed of methane from ethanol at a lab scale for the first time globally, maintaining a 100% reaction rate over a 2,000-hour initial durability test. It significantly reduces hydrogen consumption by approximately a quarter compared to conventional methanation, offering a promising solution for gas carbon neutralization while reducing electricity costs.
GABA Inhibits Muscle Protein Breakdown: New Findings from Industry-Academia Collaboration by Major Japanese Food Manufacturer
Yamamori Co., Ltd., a long-established comprehensive food manufacturer with over 130 years of history, has compiled research findings indicating that GABA (γ-aminobutyric acid), a type of amino acid, may suppress muscle protein breakdown and contribute to maintaining muscle mass. This research was conducted in collaboration with Chubu University and Nagoya University. The findings have been accepted for publication in the peer-reviewed international academic journal Food Science and Technology Research. The GABA produced by Yamamori is an amino acid manufactured via fermentation using glutamic acid as the raw material. It represents a component developed by advancing Yamamori's core technologies, such as fermentation techniques and microbial control. This study focused on skeletal muscle mass decline accelerated by the inflammatory cytokine TNF-α, which increases with aging, and verified GABA's effects using a cellular model. Experiments using mouse-derived myoblasts confirmed that GABA addition promotes muscle cell differentiation and the expression of major muscle proteins, while also suppressing TNF-α-induced muscle protein degradation. While clinical studies have been reported overseas in the past, the characteristic feature of this research is that it demonstrated the mechanism of action. GABA has been known for its functional properties such as blood pressure improvement and stress relief, but this study is significant in that it scientifically demonstrated a new function: inhibiting muscle protein degradation. It is expected to contribute to addressing social challenges such as extending healthy life expectancy in the elderly and countering muscle strength decline. Yamamori's purpose is “to pursue authenticity and deliciousness, providing foundational value for mind and body to create more excitement and smiles.” A company representative expressed enthusiasm, stating, “Moving forward, we will advance planning for the practical application of this function while also exploring new functionalities of GABA from a marketing perspective.”
Perfect Corp. Partners with PHOENIX Pharma Italia to Launch AI Skin Analysis and Product Recommendation Experience Powered by Skincare Pro in Pharmacies
Perfect Corp. (NYSE: PERF), the leading AI and AR beauty and fashion technology provider, today announced it is powering a new in-store digital innovation in the pharmacy sector through a new partnership with PHOENIX Pharma Italia.
Sweat Lactate Monitoring System Supporting Exercise Therapy Prescriptions in Cardiac Rehabilitation and Other Fields Receives Pharmaceutical Approval
Grace Imaging Co., Ltd. (Headquarters: Shinjuku-ku, Tokyo; President and CEO: Daisuke Nakajima) is pleased to announce that it has obtained manufacturing and marketing approval (pharmaceutical approval) for “SweatWatch®,” a device that evaluates exercise tolerance by monitoring lactic acid in sweat.
Furthermore, the generic name assigned to this device, “Sweat Lactic Acid Monitoring System,” makes it the first of its kind in Japan*. We will now proceed with preparations aimed at securing insurance coverage and launching the product.
Helping Others May Be an Easy Way to Keep Your Brain Young, Study Finds
Our bodies age at different rates, sometimes closely correlated to the years we've spent alive, and sometimes less so. A new study links another factor to the speed at which our brains age: how much we help others.
Regularly volunteering can reduce the rate of cognitive aging by around 15–20 percent, according to research by a team from the University of Texas at Austin (UT Austin) and the University of Massachusetts Boston in the US.
The findings are based on approximately two decades of telephone survey data from 31,303 people aged over 50. Scores on cognitive brain tests were mapped against helping behavior – whether volunteering with an organization or simply giving friends, relatives, and neighbors a hand as needed.
Bench Placement Creates Comfort: Exploring Psychological and Behavioral Aspects Fukubi Chemical Industry and Waseda University Launch New Research Project
Fukubi Chemical Industry Co., Ltd.'s Community Development Promotion Office (hereinafter referred to as Fukubi Chemical Industry Co., Ltd.) has been conducting ongoing joint research with the Sano Yuki Laboratory at Waseda University's School of Human Sciences (hereinafter referred to as Waseda University) since fiscal year 2023 to identify comfortable benches. In fiscal year 2024, we added new survey methods in locations closer to actual pedestrian spaces to clarify changes in users' psychology and behavior. The research results were presented at the Architectural Institute of Japan Annual Conference held from September 9 to 12, 2025. This fiscal year (2025), we are continuing the joint research with the addition of new perspectives. In recent years, benches, increasingly recognized as “places where people can gather,” have become more commonly installed when utilizing outdoor spaces as third places. While benches are typically placed “parallel” to the pathway they serve, the 2023 study arranged benches between building columns in four configurations: “parallel,” ‘perpendicular’ (at right angles to the pathway), “V-shaped” (with two benches facing inward), and “diagonal” (both benches angled in the same direction). The results revealed that when benches were placed “diagonally,” users selected seats according to their actions, suggesting that bench placement can influence usage patterns.
“Necoron” Sleep Support Device Prototype Unveiled for the First Time
Yukai Engineering Inc. (Headquarters: Shinjuku-ku, Tokyo; President: Shunsuke Aoki), which plans and develops numerous communication robots and IoT products under the vision “Making the world more fun with robotics,” will exhibit at CES 2026, the electronics and technology trade show held in Las Vegas, USA, from Tuesday, January 6, 2026, to Friday, January 9, 2026.
At our booth, we will showcase Yukai Engineering's latest robots, including the “Cat Tongue Puff Puff” first unveiled at last year's “CES 2025,” alongside examples of our development achievements resulting from collaborations with partner companies. We will debut the prototype of “necoron,” a baby sleep support device developed by Takara Tomy Co., Ltd., with Yukai Engineering contributing to the product design.
Furthermore, we plan to exhibit a new Yukai Engineering product making its debut at the event. Details will be announced at CES 2026.
Night waking impacts cognitive performance regardless of sleep duration
When it comes to sleep, traditional advice has focused on the number of hours a person sleeps. But for older adults, the quality of sleep may affect cognitive performance the following day regardless of their quantity of sleep, according to a new study by researchers from the Penn State College of Health and Human Development and Albert Einstein College of Medicine, Bronx, New York.
In a study published this week (Dec. 17) in Sleep Health, the researchers found that the quality of a night of sleep — rather than the length of the night of sleep — predicted how quickly older adults processed information the next day. The researchers evaluated sleep quality based on how much time someone was awake between when they first went to sleep and when they rose in the morning.